Northern Trust
IBO

Northern Trust’s Impact BioMedical IBO Stock Holding History

Northern Trust’s Portfolio IBO Stock Details IBO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$108K Sell
235,475
-8,468
-3% -$5.01K ﹤0.01% 4108
2026
Q1 		$146K Buy
243,943
+233,718
+2,286% +$117K ﹤0.01% 4026
2025
Q4 		$5.16K Buy
+10,225
New +$5.41K ﹤0.01% 4446

Other funds holding IBO

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Vanguard Global Advisers
Vanguard Global Advisers Malvern, Pennsylvania $215B AUM
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
MAC
Mason & Associates (California) Los Angeles, California $619M AUM 29.44% 1-Year Est. Return

Northern Trust's IBO Position: Q2 2026 in Review

Northern Trust reduced its Impact BioMedical (IBO) stake by 3.5% in Q2 2026, selling an estimated $5.01K and leaving 235,475 shares worth $108K. The position accounts for ﹤0.01% of the portfolio, ranked #4108.

Northern Trust first reported a position in IBO in Q4 2025 and has held it in 3 quarters since. The position peaked at $146K in Q1 2026. 22 funds tracked by Wall St. Rank hold IBO as of Q2 2026.

  • Northern Trust held 235,475 shares of Impact BioMedical worth $108K as of Q2 2026.
  • Northern Trust sold 8,468 Impact BioMedical shares in Q2 2026, an estimated $5.01K.
  • Impact BioMedical made up ﹤0.01% of Northern Trust's portfolio in Q2 2026, its #4108 holding.
  • Northern Trust first reported a position in Impact BioMedical in Q4 2025 and has held it in 3 quarters since.
  • Northern Trust's Impact BioMedical position peaked at $146K in Q1 2026.
  • 22 funds tracked by Wall St. Rank held Impact BioMedical as of Q2 2026.

Based on Northern Trust's 13F filing for Q2 2026, filed 13 Aug 2026.